Cellular therapy and tissue engineering for cartilage repair

• Published in: Osteoarthritis and cartilage Vol. 30; no. 12; pp. 1547 - 1560
• Main Authors: Zelinka, A., Roelofs, A.J., Kandel, R.A., De Bari, C.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.12.2022
• Subjects: Cartilage repair; Cartilage, Articular; Cell- and Tissue-Based Therapy; Chondrocytes - physiology; Humans; Mesenchymal Stem Cells - metabolism; Osteoarthritis; Regenerative medicine; Stem cells; Tissue Engineering; Tissue Scaffolds - chemistry; Cartilage repair; Tissue engineering; Regenerative medicine; Osteoarthritis; Stem cells
• ISSN: 1063-4584; 1522-9653
• DOI: 10.1016/j.joca.2022.07.012

Articular cartilage (AC) has limited capacity for repair. The first attempt to repair cartilage using tissue engineering was reported in 1977. Since then, cell-based interventions have entered clinical practice in orthopaedics, and several tissue engineering approaches to repair cartilage are in the translational pipeline towards clinical application. Classically, these involve a scaffold, substrate or matrix to provide structure, and cells such as chondrocytes or mesenchymal stromal cells to generate the tissue. We discuss the advantages and drawbacks of the use of various cell types, natural and synthetic scaffolds, multiphasic or gradient-based scaffolds, and self-organizing or self-assembling scaffold-free systems, for the engineering of cartilage constructs. Several challenges persist including achieving zonal tissue organization and integration with the surrounding tissue upon implantation. Approaches to improve cartilage thickness, organization and mechanical properties include mechanical stimulation, culture under hypoxic conditions, and stimulation with growth factors or other macromolecules. In addition, advanced technologies such as bioreactors, biosensors and 3D bioprinting are actively being explored. Understanding the underlying mechanisms of action of cell therapy and tissue engineering approaches will help improve and refine therapy development. Finally, we discuss recent studies of the intrinsic cellular and molecular mechanisms of cartilage repair that have identified novel signals and targets and are inspiring the development of molecular therapies to enhance the recruitment and cartilage reparative activity of joint-resident stem and progenitor cells. A one-fits-all solution is unrealistic, and identifying patients who will respond to a specific targeted treatment will be critical.